We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
-5.72%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$322M
AUM Growth
-$34.8M
Cap. Flow
-$3.33M
Cap. Flow %
-1.03%
Top 10 Hldgs %
62.73%
Holding
76
New
14
Increased
20
Reduced
18
Closed
19

Top Buys

Rank Stock Value
1
ENSG icon
The Ensign Group
ENSG
+$14.9M
2
GSK icon
GSK
GSK
+$11.9M
3
ASND icon
Ascendis Pharma A/S
ASND
+$11.2M
4
NVST icon
Envista
NVST
+$8.88M
5
DXCM icon
DexCom
DXCM
+$6.92M

Top Sells

Rank Stock Value
1
RCM
R1 RCM Inc. Common Stock
RCM
+$23.3M
2
EHTH icon
eHealth
EHTH
+$12.3M
3
RDUS
Radius Health, Inc.
RDUS
+$8.96M
4
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$8.38M
5
NUVA
NuVasive, Inc.
NUVA
+$5.37M

Sector Composition

Rank Sector Weight
1 Healthcare 90.47%
2 Real Estate 4.59%
3 Industrials 2.01%
4 Communication Services 1.04%
5 Miscellaneous 1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
1
GSK
GSK
$102B
$42.3M 13.13%
786,468
+231,520
+42% +$11.9M
ENSG icon
2
The Ensign Group
ENSG
$10.1B
$27.8M 8.64%
627,155
+300,594
+92% +$14.9M
DHR icon
3
Danaher
DHR
$152B
$25.8M 8.02%
201,578
+37,901
+23% +$4.75M
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
$25.8M 8%
643,818
+107,024
+20% +$4.93M
ASND icon
5
Ascendis Pharma A/S
ASND
$16.3B
$22.8M 7.06%
236,392
+99,995
+73% +$11.2M
AMRN
6
Amarin Corp
AMRN
$295M
$20.2M 6.25%
66,485
-11,418
-15% -$3.99M
SNY icon
7
Sanofi
SNY
$107B
$11.1M 3.45%
240,000
-26,062
-10% -$1.12M
RDUS
8
DELISTED
Radius Health, Inc.
RDUS
$8.88M 2.75%
344,698
-365,819
-51% -$8.96M
NVST icon
9
Envista
NVST
$4.36B
$8.87M 2.75%
+318,000
New +$8.88M
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$137B
$8.63M 2.68%
50,909
-6,940
-12% -$1.23M
ILMN icon
11
Illumina
ILMN
$32.6B
$8.14M 2.52%
27,499
+8,697
+46% +$2.56M
ALNY icon
12
Alnylam Pharmaceuticals
ALNY
$31.7B
$7.4M 2.3%
92,040
+4,900
+6% +$388K
BOLD
13
DELISTED
Audentes Therapeutics, Inc
BOLD
$7.13M 2.21%
253,726
+94,200
+59% +$3.21M
DXCM icon
14
DexCom
DXCM
$34.3B
$6.65M 2.06%
+178,200
New +$6.92M
RCM
15
DELISTED
R1 RCM Inc. Common Stock
RCM
$6.48M 2.01%
725,972
-1,973,187
-73% -$23.3M
ABMD
16
DELISTED
Abiomed Inc
ABMD
$5.33M 1.65%
+29,950
New +$6.47M
OHI icon
17
Omega Healthcare
OHI
$13.9B
$4.45M 1.38%
106,500
+65,100
+157% +$2.54M
TGTX icon
18
TG Therapeutics
TGTX
$8.26B
$4.34M 1.35%
773,501
-110,000
-12% -$767K
OXFD
19
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$4.26M 1.32%
+256,000
New +$3.54M
TLGT
20
DELISTED
Teligent, Inc
TLGT
$4.2M 1.3%
442,422
+183,934
+71% +$1.45M
ARGX icon
21
argenx
ARGX
$64B
$4.1M 1.27%
36,004
-12,260
-25% -$1.66M
LTC
22
LTC Properties
LTC
$2.19B
$3.55M 1.1%
69,327
+36,300
+110% +$1.75M
SBRA icon
23
Sabra Healthcare REIT
SBRA
$5.27B
$3.54M 1.1%
154,100
+75,500
+96% +$1.61M
MODN
24
DELISTED
MODEL N, INC.
MODN
$3.35M 1.04%
+120,695
New +$3M
CTRE icon
25
CareTrust REIT
CTRE
$9.22B
$3.26M 1.01%
137,464
+75,000
+120% +$1.76M
1
2 3 4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Eversept Partners held 76 positions worth $322M, down 9.7% from $357M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Eversept Partners's Q3 2019 filing shows 14 new, 20 increased, 18 reduced and 19 closed positions. Its largest new stake was Envista: 318,000 shares worth $8.87M. The largest sale was R1 RCM Inc. Common Stock, an estimated $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 82% a quarter earlier, followed by Real Estate and Industrials.

  • Eversept Partners's largest Q3 2019 buy was Envista: 318,000 shares worth $8.87M.
  • Eversept Partners added most to The Ensign Group in Q3 2019, an estimated $14.9M increase.
  • Eversept Partners's biggest Q3 2019 reduction was R1 RCM Inc. Common Stock, cutting an estimated $23.3M.
  • Eversept Partners fully exited NuVasive, Inc. in Q3 2019, selling an estimated $5.37M.
  • Eversept Partners's ten largest holdings make up 63% of its $322M portfolio in Q3 2019.
  • Eversept Partners opened 14 new positions and closed 19 in Q3 2019.
  • Eversept Partners's portfolio value fell 9.7% quarter-over-quarter to $322M.

Based on Eversept Partners's 13F filing for Q3 2019, filed 13 Nov 2019.